Wit, F.W.N.M.

International Migration, Integration and Social Cohesion online publications

UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl)UvA-DARE (Digital Academic Repository)Studies on the efficacy and toxicity of highly active antiretroviral therapyWit, F.W.N.M.Publication date2002Link to publicationCitation for published version (APA):Wit, F. W. N. M. (2002). Studies on the efficacy and toxicity of highly active antiretroviraltherapy. [Thesis, fully internal, Universiteit van Amsterdam].General rightsIt is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s)and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an opencontent license (like Creative Commons).Disclaimer/Complaints regulationsIf you believe that digital publication of certain material infringes any of your rights or (privacy) interests, pleaselet the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the materialinaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letterto: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. Youwill be contacted as soon as possible.Download date:11 Mar 2023ListList of publications Listt of publications 1.. Wit FWNM, van Rij RP, Weverling GJ, Lange JMA, Schuitemaker H. CCR5 A32 and CCR22 641 polymorphisms do not influence the virological and immunological responsee to antiretrovira l combination therapy. Submitted for publication. 2.2. Wit FWNM, Weverling GJ, Weel J, Jurriaans S, Lange JMA. Incidence of and risk factor ss for  severe hepatotoxici ty of antiretrovira l combination therapy. Submitted forfor publication. 3.. Kirk 0 , Reiss P, Uberti-Foppa C, Bickel M, Gerstoft J, Pradier C, Wit FWNM, Ledergerber B,, Lundgren JD, Furrer H, for seven European HIV cohorts. Safe interrupt io n of maintenancee therapy against prio r  infection wit h four  common HIV-associated opportunist i cc pathogens durin g highly active antiretrovira l therapy. Submitted for publication. publication. 4.. ADHOC International Steering Committee. A randomised placebo controlled tria l of adefovirr  dipivoxi l in advanced HI V infection. Submitted for publication. 5.. Dieleman J, Sturkenboom M, Wit FWNM, Jambroes M, Mulder JW, ten Veen J, Ju t tmann J,, Strieker B, Lange J, van der Ende M. Low risk of treatment failur e one year  after subst i tut in gg nevirapine for  human immunodefic iency viru s (HIV)-protease inhibitor ss among HIV-infecte d patients wit h vira l suppression in a real lif e sett ing.. The ATHEN A cohort. Submitted for publication. 6.. Hazenberg M, Otto SA, van Baarle A, Kostense S, Wit FWNM, Lange JMA, Hamann D, Miedemaa F. Discordant Responses durin g antiretrovira l therapy: rol e for  immune act ivat ionn and T-cell redistribution . AIDS, in press. 7.. van Praag ME, Wit FWNM, Jurr iaans S, de Wolf F, Prins JM, Lange JMA. Improved long-termm suppress ion of HIV- 1 repl icat ion wit h a tr iple-class mul t idru g reg imenn compared to standard of care ant iretrovira l therapy. AIDS, in press. 8.. Wit FWNM, Wood R, Horban A, Beniowski M, Schmidt RE, Gray G, Lazzarin A, Lafeuilladee A, Paes D, Carlier H, van Weert L, de Vries C, van Leeuwen R, Lange JMA. Prednisolonee does not prevent hypersensit iv i ty react ions in antiretrovira l dru g regimenss containing abacavir  wit h or  withou t nevirapine. AIDS 2001; 15: 2423-2429. . 179 9 ListList of publications 9.. van der Valk M, Gisolf EH, Reiss P, Wit FWNM, Japour A, Weverling GJ et al. Increased riskk of l ipodystrophy when nucleoside analogue reverse transcriptase inhibitor s ar ee inc luded wi t h protease inhibitor s in the treatment of HIV- 1 infection. AIDS 2001;; 15: 847-855. 10.. Reijers MH, Weverling GJ, Jurriaans S, Roos MT, Wit FWNM, Weigel HM, Ten Kate RW, Mulderr JW, Richter C, Ter Hofstede HJ, Sprenger H, Hoetelmans RM, Schuitemaker H, Langee JM. The ADA M study continued: maintenance therapy after  50 weeks of induct io nn therapy. AIDS. 2001 Jan 5;15(1):129-31. 11.. den Brinker M, Wit FWNM, Wertheim-van Dillen PM, Jurriaans S, Weel J, van Leeuwen R,, Pakker NG, Reiss P, Danner SA, Weverling GJ, Lange JM. Hepatit i s B and C viru s co-infect ionn and the risk for  hepatotoxici ty of highly active antiretrovira l therapyy in HIV- 1 infection. AIDS. 2000 Dec 22;14(18):2895-902. 12.. Wit FWNM. Exper ience wi t h nevirapine in previously treated HIV-1-infected individuals .. Dutch HRf-treating physicians. Antivir Ther. 2000 Dec;5(4):257-66. 13.. van Heeswijk RP, Veldkamp AI, Mulder JW, Meenhorst PL, Wit FWNM, Reiss P, Lange JM,, Kwakkelstein MO, Beijnen JH, Hoetelmans RM. Nevirapine plus didanosine: once orr  twice daily combinat ion? J Acquir Immune Defie Syndr. 2000 Sep l;25(l):93-5. 14.. Clark DR, Repping S, Pakker NG, Prins JM, Notermans DW, Wit FWNM, Reiss P, Danner SA,, Coutinho RA, Lange JM, Miedema F. T-cell progenitor  function dur in g progressivee human immunodeficiency virus-1 infection and after  antiretrovira l therapy.. Blood. 2000 Jul l;96(l):242-9. 15.. van Heeswijk RP, Veldkamp AI, Mulder JW, Meenhorst PL, Wit FWNM, Lange JM, Dannerr SA, Foudraine NA, Kwakkelstein MO, Reiss P, Beijnen JH, Hoetelmans RM. The steady-statee pharmacokinet ics of nevirapine durin g once daily and twice daily dos ingg in HIV-1-infected individuals . AIDS. 2000 May 26;14(8):F77-82. 16.. Pakker NG, Kroon ED, Roos MT, Otto SA, Hall D, Wit FWNM, Hamann D, van der Ende ME,, Claessen FA, Kauffmann RH, Koopmans PP, Kroon FP, ten Napel CH, Sprenger HG, Weigell HM, Montaner JS, Lange JM, Reiss P, Schellekens PT, Miedema F. Immun e restorat ionn does not invariabl y occur  followin g long-term HIV- 1 suppression dur in gg ant iretrovira l therapy. INCAS Study Group. AIDS. 1999 Feb 4;13(2):203-12. 180 0 ListList of publications 17.. Wit FWNM, van Leeuwen R, Weverling GJ, Jurr iaans S, Nauta K, Steingrover R, Schuijtemakerr J, Eyssen X, Fortuin D, Weeda M, de Wolf F, Reiss P, Danner SA, Lange JM. Outcomee and predictor s of failur e of highly active antiretrovira l therapy: one-yearr  follow-up of a cohort of human immunodeficiency viru s type 1-infected persons.. J Infect Dis. 1999 Apr;179(4):790-8. 18.. Reijers MH, Weverling GJ, Jurriaans S, Wit FWNM, van Leeuwen R, Bruisten SM, Frissen PH,, Weigel HM, Mulder JW, ten Kate RW, de Wolf F, Schuitemaker H, Lange JM. [Amsterdamm durat io n of antiretrovira l medicat ion (ADAM)-study : induct ion-suppressionn treatment in HIV- I  infection, preliminar y results]. Ned Tijdschr Geneeskd.Geneeskd. 1998 Oct 3;142(40):2230. 19.. Hoetelmans RM, Reijers MH, Weverling GJ, ten Kate RW, Wit FWNM, Mulder JW, Weigel HM,, Frissen PH, Roos M, Jurriaans S, Schuitemaker H, de Wolf F, Beijnen JH, Lange JM. Th ee effect of plasma dru g concentrat ions on HIV- 1 clearance rat e durin g quadrupl ee dru g therapy. AIDS. 1998 Jul 30;12(l l ) :Fl l l -5. 20.. Reijers MH, Weverling GJ, Jurriaans S, Wit FWNM, Weigel HM, Ten Kate RW, Mulder JW,, Frissen PH, van Leeuwen R, Reiss P, Schuitemaker H, de Wolf F, Lange JM. Maintenancee therapy after  quadrupl e induction therapy in HIV- 1 infected individuals ::  Amsterdam Duratio n of Antiretrovira l Medication (ADAM ) study. Lancet.Lancet. 1998 Jul 18;352(9123):185-90. 21.. Wit FWNM, Sol CJ, Renwick N, Roos MT, Pals ST, van Leeuwen R, Goudsmit J, Reiss P. Regressionn of AIDS-related Kaposi's sarcoma associated wit h clearance of human herpesvirus-88 fro m peripheral blood mononuclear  cells fol lowin g ini t iat io n of antiretrovira ll  therapy. AIDS. 1998 Jan 22;12(2):218-9. 22.. Kuijper EJ, Wit FWNM, Veenstra J, Bottger EC. Recovery of Mycobacterium haemophi lumm skin infection in an HrV- 1 infected patient after  the start of antiretrovira ll  tripl e therapy. Clinical Microbiology and Infection. 1997 Oct;3(5):584-5. 181 1 

English

Studies on the efficacy and toxicity of highly active antiretroviral therapy

https://pure.uva.nl/ws/files/3498155/24453_UBA002000846_15.pdf

Studies on the efficacy and toxicity of highly active antiretroviral therapy

Abstract

Similar works

Full text

Available Versions

International Migration, Integration and Social Cohesion online publications